Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucas Moreno

Showing results (91-100 of 122) with videos related to

Pageof 13
Sort By:
Biorxiv : the Preprint Server for Biology|February 26, 2024
BPTF cooperates with MYCN and MYC to link neuroblastoma cell cycle control to epigenetic cellular statesIrene Felipe, Jaime Martínez-de-Villarreal, Khushbu Patel, et al.
NPJ Precision Oncology|July 2, 2026
Loss of BAX in a neuroblastoma patient reveals delayed apoptosis but sustained chemotherapy sensitivityAdrià Molero-Valenzuela, Isabel de Rojas-P, Guillem Pons, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 3, 2025
Implementation of the precision oncology program in catalonia's public health system: results, lessons learned, and future prospectsPilar Mur, Anna Pozuelo, Josep Tabernero, et al.
European Journal of Cancer (Oxford, England : 1990)|June 25, 2018
Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancerLucas Moreno, Michela Casanova, Julia C Chisholm, et al.
Cancer Research|March 17, 2019
MRI Imaging of the Hemodynamic Vasculature of Neuroblastoma Predicts Response to Antiangiogenic TreatmentKonstantinos Zormpas-Petridis, Neil P Jerome, Matthew D Blackledge, et al.
Journal of Neuro-Oncology|May 16, 2016
Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine gliomaFernando Carceller, Lucy A Fowkes, Komel Khabra, et al.
Cancer Research|June 10, 2026
SMARCB1 Deficiency in Tumors Confers a Vulnerability to H3K27 Demethylase Inhibitors via Autophagy DisruptionAndrea Vilarrubi, Gabriela Guillén, Xiaoyu Liu, et al.
Cancer Medicine|May 21, 2026
Assessing the Validity and Acceptability of an Adult Quality of Life Questionnaire, the EORTC QLQ-C30, for Adolescents With CancerSamantha C Sodergren, David Riedl, Jamal Hossain, et al.
Cellular and Molecular Life Sciences : CMLS|October 11, 2022
Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastomaNatalia Navarro, Carla Molist, Júlia Sansa-Girona, et al.
Cancer|February 11, 2025
A phase 1 dose-escalation study of LY3295668 erbumine as monotherapy and in combination with topotecan and cyclophosphamide in children with relapsed/refractory neuroblastomaSteven G DuBois, Chitose Ogawa, Lucas Moreno, et al.
Pageof 13

Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
Biorxiv : the Preprint Server for Biology|February 26, 2024
BPTF cooperates with MYCN and MYC to link neuroblastoma cell cycle control to epigenetic cellular statesIrene Felipe, Jaime Martínez-de-Villarreal, Khushbu Patel, et al.
NPJ Precision Oncology|July 2, 2026
Loss of BAX in a neuroblastoma patient reveals delayed apoptosis but sustained chemotherapy sensitivityAdrià Molero-Valenzuela, Isabel de Rojas-P, Guillem Pons, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 3, 2025
Implementation of the precision oncology program in catalonia's public health system: results, lessons learned, and future prospectsPilar Mur, Anna Pozuelo, Josep Tabernero, et al.
European Journal of Cancer (Oxford, England : 1990)|June 25, 2018
Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancerLucas Moreno, Michela Casanova, Julia C Chisholm, et al.
Cancer Research|March 17, 2019
MRI Imaging of the Hemodynamic Vasculature of Neuroblastoma Predicts Response to Antiangiogenic TreatmentKonstantinos Zormpas-Petridis, Neil P Jerome, Matthew D Blackledge, et al.
Journal of Neuro-Oncology|May 16, 2016
Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine gliomaFernando Carceller, Lucy A Fowkes, Komel Khabra, et al.
Cancer Research|June 10, 2026
SMARCB1 Deficiency in Tumors Confers a Vulnerability to H3K27 Demethylase Inhibitors via Autophagy DisruptionAndrea Vilarrubi, Gabriela Guillén, Xiaoyu Liu, et al.
Cancer Medicine|May 21, 2026
Assessing the Validity and Acceptability of an Adult Quality of Life Questionnaire, the EORTC QLQ-C30, for Adolescents With CancerSamantha C Sodergren, David Riedl, Jamal Hossain, et al.
Cellular and Molecular Life Sciences : CMLS|October 11, 2022
Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastomaNatalia Navarro, Carla Molist, Júlia Sansa-Girona, et al.
Cancer|February 11, 2025
A phase 1 dose-escalation study of LY3295668 erbumine as monotherapy and in combination with topotecan and cyclophosphamide in children with relapsed/refractory neuroblastomaSteven G DuBois, Chitose Ogawa, Lucas Moreno, et al.
Pageof 13